Table 2.
Groups | Bax/GAPDH | Caspase-3/GAPDH | Bcl-2/GAPDH |
---|---|---|---|
Control | 0.105 ± 0.001 | 0.055 ± 0.002 | 0.529 ± 0.002 |
MTD NVB | 0.443 ± 0.002 | 0.168 ± 0.001 | 0.380 ± 0.001 |
Endo+MTD NVB | 0.698 ± 0.003** | 0.514 ± 0.002** | 0.148 ± 0.001** |
Endo | 0.068 ± 0.001 | 0.036 ± 0.001 | 0.694 ± 0.003 |
MET NVB | 0.571 ± 0.002 | 0.359 ± 0.001 | 0.375 ± 0.001 |
Endo+MET NVB | 0.748 ± 0.003** | 0.602 ± 0.003** | 0.061 ± 0.001** |
Data are presented as the mean ± SD. *P < 0.05, **P < 0.01 versus the control group; #P < 0.05, ##P < 0.01 versus the MET NVB+ Endo group